Back
Speaker illustration

Doctor Federica Marzano

University of Naples Federico II, Naples (Italy)

Member of:

European Society of Cardiology

Presentations

Therapeutic implementation in patients with newly diagnosed heart failure: data from the italian multicenter registry OpTIMa-HF

Event: ESC Congress 2025

Topic: Pharmacotherapy

Session: Challenges and strategies in heart failure care

Access
Like
Thumbnail

Efficacy and safety of inclisiran in patients with and without type 2 diabetes mellitus: a subgroup analysis from the CHOLINET Registry

Event: ESC Congress 2025

Topic: Lipid-Lowering Agents

Session: Novel insights into lipid-lowering pharmacotherapy

Access
Like
Thumbnail

Efficacy and safety of inclisiran in real-world clinical practice. Results from the CHOLINET Registry

Event: ESC Congress 2024

Topic: Lipid-Lowering Agents

Session: Lipid-lowering therapy: statins and beyond

Access
Like
Thumbnail

Strike early-strike strong lipid-lowering strategy with PCSK9i in ACS patients. Real-world evidence from AT-TARGET-IT registry.

Event: ESC Congress 2024

Topic: Pharmacotherapy

Session: Lipid-lowering treatment: impact on the atherosclerotic plaque and outcomes

Access
Like
Thumbnail

GRK5 controls basal cardiac function and survival via direct p53 modulation

Event: Heart Failure 2021

Topic: Heart Failure

Session: Basic Science

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources